The UK government’s EU External Affairs Subcommittee on Tuesday published a report on the implications of Brexit on trade, noting that there may be “significant benefits” in continuing UK participation in the European Medicines Agency (EMA).
http://www.raps.org/Regulatory-Focus/News/2017/03/14/27109/UK-on-Brexit-Implications-%E2%80%98Significant-Benefits%E2%80%99-to-Remain-Part-of-EMA/